As of 2026-03-20, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 1.70 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 6.17 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -72.5%.
The range of the Relative Valuation is (0.04) - 5.09 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.1x - 3.9x | 2.5x |
| Forward P/E multiples | 18.6x - 50.4x | 34.5x |
| Fair Price | (0.04) - 5.09 | 1.70 |
| Upside | -100.6% - -17.4% | -72.5% |
| Date | P/E |
| 2026-03-18 | -174.40 |
| 2026-03-17 | -173.83 |
| 2026-03-16 | -173.55 |
| 2026-03-13 | -172.42 |
| 2026-03-12 | -172.42 |
| 2026-03-11 | -174.96 |
| 2026-03-10 | -177.22 |
| 2026-03-09 | -175.24 |
| 2026-03-06 | -174.11 |
| 2026-03-05 | -175.81 |
| 2026-03-04 | -177.79 |
| 2026-03-03 | -176.09 |
| 2026-03-02 | -179.20 |
| 2026-02-27 | -177.50 |
| 2026-02-26 | -180.05 |
| 2026-02-25 | -178.07 |
| 2026-02-24 | -180.33 |
| 2026-02-23 | -185.42 |
| 2026-02-20 | -182.03 |
| 2026-02-19 | -183.44 |
| 2026-02-18 | -185.14 |
| 2026-02-17 | -180.90 |
| 2026-02-13 | -178.64 |
| 2026-02-12 | -168.74 |
| 2026-02-11 | -166.76 |
| 2026-02-10 | -165.92 |
| 2026-02-09 | -168.18 |
| 2026-02-06 | -166.20 |
| 2026-02-05 | -165.07 |
| 2026-02-04 | -166.48 |
| 2026-02-03 | -167.33 |
| 2026-02-02 | -167.05 |
| 2026-01-30 | -163.94 |
| 2026-01-29 | -163.94 |
| 2026-01-28 | -164.50 |
| 2026-01-27 | -163.09 |
| 2026-01-26 | -165.07 |
| 2026-01-23 | -167.33 |
| 2026-01-22 | -164.22 |
| 2026-01-21 | -162.81 |
| 2026-01-20 | -162.81 |
| 2026-01-19 | -164.79 |
| 2026-01-16 | -167.05 |
| 2026-01-15 | -168.74 |
| 2026-01-14 | -169.03 |
| 2026-01-13 | -167.05 |
| 2026-01-12 | -171.00 |
| 2026-01-09 | -169.03 |
| 2026-01-08 | -168.46 |
| 2026-01-07 | -170.16 |